FinanceModerna Surges 125% YTD: mRNA Flu Vaccine Approval, Pipeline Expansion, and What's Driving the Rally
Moderna shares have surged over 125% year to date, driven by a unanimous FDA advisory vote on its mRNA flu vaccine, a major corporate restructuring, and a wave of pipeline announcements signaling a broader commercial strategy beyond COVID-19.
June 29, 2026